Page 95 - Read Online

Papaluca et al. Hepatoma Res 2018;4:64 I http://dx.doi.org/10.20517/2394-5079.2018.53 Page 9 of 10

1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-128.
6. Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, et al. The global burden of viral hepatitis from 1990 to 2013: findings from
the Global Burden of Disease Study 2013. Lancet 2016;388:1081-8.
7. de Martel C, Maucort-Boulch D, Plummer M, Franceschi S. World-wide relative contribution of hepatitis B and C viruses in hepatocellular
carcinoma. Hepatology 2015;62:1190-200.
8. Okanoue T, Sakamoto S, Itoh Y, Minami M, Yasui K, et al. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol
1996;25:283-91.
9. WHO. Combating hepatitis B and C to reach elimination by 2030: advocacy brief. Available from: https://www.who.int/hepatitis/
publications/hep-elimination-by-2030-brief/en/. [Last accessed on 9 Oct 2018]
10. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject
drugs: results of systematic reviews. Lancet 2011;378:571-83.
11. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007;13:2436-41.
12. Scott N, Doyle JS, Wilson DP, Wade A, Howell J, et al. Reaching hepatitis C virus elimination targets requires health system interventions
to enhance the care cascade. Int J Drug Policy 2017;47:107-16.
13. Walmsley R; Internation Centre for Prison Studies. World prison population list (tenth edition). Available from: https://www.prisonstudies.
org/sites/default/files/resources/downloads/wppl_10.pdf. [Last accessed on 9 Oct 2018]
14. Wagner P, Rabuy B; Prison Policy Initiative. Mass incarceration: the whole pie 2016. Available from: https://www.prisonpolicy.org/reports/
pie2018.html. [Last accessed on 9 Oct 2018]
15. Dolan K, Wirtz AL, Moazen B, Ndeffo-Mbah M, Galvani A, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and
detainees. Lancet 2016;388:1089-102.
16. Murphy EL, Bryzman SM, Glynn SA, Ameti DI, Thomson RA, et al. Risk factors for hepatitis C virus infection in United States blood
donors. Hepatology 2000;31:756-62.
17. Jürgens R, Nowak M, Day M. HIV and incarceration: prisons and detention. J Int AIDS Soc 2011;14:26.
18. Beckman AL, Bilinski A, Boyko R, Camp GM, Wall AT, et al. New hepatitis C drugs are very costly and unavailable to many state
prisoners. Health Aff (Millwood) 2016;35:1893-901.
19. DeBeck K, Cheng T, Montaner JS, Beyrer C, Elliott R, et al. HIV and the criminalisation of drug use among people who inject drugs: a
systematic review. Lancet HIV 2017;4:e357-74.
20. Larney S, Kopinski H, Beckwith CG, Zaller ND, Jarlais DD, et al. Incidence and prevalence of hepatitis C in prisons and other closed
settings: results of a systematic review and meta-analysis. Hepatology 2013;58:1215-24.
21. Boonwaat L, Haber PS, Levy MH, Lloyd AR. Establishment of a successful assessment and treatment service for Australian prison inmates
with chronic hepatitis C. Med J Aust 2010;192:496-500.
22. Lloyd AR, Clegg J, Lange J, Stevenson A, Post JJ, et al. Safety and effectiveness of a nurse-led outreach program for assessment and
treatment of chronic hepatitis C in the custodial setting. Clin Infect Dis 2013;56:1078-84.
23. WHO. Prisons and health. Available from: https://www.euro.who.int/__data/assets/pdf_file/0005/249188/Prisons-and-Health.pdf. [Last
accessed on 9 Oct 2018]
24. ECDC. Technical report: surveillance and prevention of hepatitis B and C in Europe. Available from: https://ecdc.europa.eu/sites/portal/
files/media/en/publications/Publications/101012_TER_HepBandC_survey.pdf. [Last accessed on 9 Oct 2018]
25. Spaulding AC, Weinbaum CM, Lau DT, Sterling R, Seeff LB, et al. A framework for management of hepatitis C in prisons. Ann Intern Med
2006;144:762-9.
26. Imperial JC. Chronic hepatitis C in the state prison system: insights into the problems and possible solutions. Expert Rev Gastroenterol
Hepatol 2010;4:355-64.
27. De P, Connor N, Bouchard F, Sutherland D. HIV and hepatitis C virus testing and seropositivity rates in Canadian federal penitentiaries: a
critical opportunity for care and prevention. Can J Infect Dis Med Microbiol 2004;15:221-5.
28. Kirwan P, Evans B; Sentinel Surveillance of Hepatitis Testing Study Group, Brant L. Hepatitis C and B testing in English prisons is low but
increasing. J Public Health (Oxf) 2011;33:197-204.
29. Rich JD, Beckwith CG, Macmadu A, Marshall BDL, Brinkley-Rubinstein L, et al. Clinical care of incarcerated people with HIV, viral
hepatitis, or tuberculosis. Lancet 2016;388:1103-14.
30. Post JJ, Arain A, Lloyd AR. Enhancing assessment and treatment of hepatitis C in the custodial setting. Clin Infect Dis 2013; doi: 10.1093/
cid/cit265.
31. Khaw FM, Stobbart L, Murtagh MJ. ‘I just keep thinking I haven’t got it because I’m not yellow’: a qualitative study of the factors that
influence the uptake of hepatitis C testing by prisoners. BMC Public Health 2007;7:98.
32. Hickman M, McDonald T, Judd A, Nichols T, Hope V, et al. Increasing the uptake of hepatitis C virus testing among injecting drug users in
specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial. J Viral
Hepat 2008;15:250-4.
33. Humphreys C, Railton C, O’Moore É, Lombard M, Newton A. An audit of hepatitis C service provision in a representative sample of
prisons in England. J Public Health (Oxf) 2015;37:151-6.
34. Hochstatter KR, Stockman LJ, Holzmacher R, Greer J, Seal DW, et al. The continuum of hepatitis C care for criminal justice involved
adults in the DAA era: a retrospective cohort study demonstrating limited treatment uptake and inconsistent linkage to community-based
care. Health Justice 2017;5:10.
35. Mina MM, Herawati L, Butler T, Lloyd A. Hepatitis C in Australian prisons: a national needs assessment. Int J Prison Health 2016;12:3-16.
36. Yap L, Carruthers S, Thompson S, Cheng W, Jones J, et al. A descriptive model of patient readiness, motivators, and hepatitis C treatment
uptake among Australian prisoners. PLoS One 2014; doi: 10.1371/journal.pone.0087564.
37. James DJ, Glaze LE; Bureau of Justice Statistics Washington. Mental health problems of prison and jail inmates. Available from: https://